These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells. Zanellato I; Colangelo D; Osella D Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Fischer B; Frei C; Moura U; Stahel R; Felley-Bosco E Lung Cancer; 2012 Oct; 78(1):23-9. PubMed ID: 22857894 [TBL] [Abstract][Full Text] [Related]
4. Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma. Kopecka J; Salaroglio IC; Righi L; Libener R; Orecchia S; Grosso F; Milosevic V; Ananthanarayanan P; Ricci L; Capelletto E; Pradotto M; Napoli F; Di Maio M; Novello S; Rubinstein M; Scagliotti GV; Riganti C Lung Cancer; 2018 Jun; 120():34-45. PubMed ID: 29748013 [TBL] [Abstract][Full Text] [Related]
5. Butein impairs the protumorigenic activity of malignant pleural mesothelioma cells. Cioce M; Canino C; Pulito C; Muti P; Strano S; Blandino G Cell Cycle; 2012 Jan; 11(1):132-40. PubMed ID: 22185775 [TBL] [Abstract][Full Text] [Related]
6. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma. Yamamoto K; Seike M; Takeuchi S; Soeno C; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A Oncol Rep; 2014 Dec; 32(6):2365-72. PubMed ID: 25231602 [TBL] [Abstract][Full Text] [Related]
7. Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed. Cortes-Dericks L; Carboni GL; Schmid RA; Karoubi G Int J Oncol; 2010 Aug; 37(2):437-44. PubMed ID: 20596671 [TBL] [Abstract][Full Text] [Related]
12. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro. Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118 [TBL] [Abstract][Full Text] [Related]
13. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma. Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045 [TBL] [Abstract][Full Text] [Related]
14. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy. Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348 [TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma. Xu D; Liang SQ; Yang H; Lüthi U; Riether C; Berezowska S; Marti TM; Hall SRR; Bruggmann R; Kocher GJ; Schmid RA; Peng RW Br J Cancer; 2018 Jul; 119(1):65-75. PubMed ID: 29921948 [TBL] [Abstract][Full Text] [Related]
16. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma]. Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136 [TBL] [Abstract][Full Text] [Related]
17. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma. Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243 [TBL] [Abstract][Full Text] [Related]
18. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application. Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921 [TBL] [Abstract][Full Text] [Related]
19. Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation. Cioce M; Canino C; Goparaju C; Yang H; Carbone M; Pass HI Cell Death Dis; 2014 Apr; 5(4):e1167. PubMed ID: 24722292 [TBL] [Abstract][Full Text] [Related]
20. Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6. Cioce M; Gatti V; Napolitano F; Giorgiano NM; Marra A; Portella G; Fiorelli A; Pentimalli F; Fazio VM Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]